VisionPoint Advisory Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$377K Sell
1,962
-57
-3% -$9.27K 0.06% 295
2026
Q2
$275K Buy
+2,019
New +$248K 0.04% 379
2026
Q1
– Sell
-1,434
Closed -$235K – 473
2025
Q4
$235K Buy
+1,434
New +$225K 0.05% 353

Other funds holding RGEN

VisionPoint Advisory Group's RGEN Position: Q3 2026 in Review

VisionPoint Advisory Group reduced its Repligen (RGEN) stake by 2.8% in Q3 2026, selling an estimated $9.27K and leaving 1,962 shares worth $377K. The position accounts for 0.06% of the portfolio, ranked #295.

VisionPoint Advisory Group first reported a position in RGEN in Q4 2025 and has held it in 3 quarters since. 76 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • VisionPoint Advisory Group held 1,962 shares of Repligen worth $377K as of Q3 2026.
  • VisionPoint Advisory Group sold 57 Repligen shares in Q3 2026, an estimated $9.27K.
  • Repligen made up 0.06% of VisionPoint Advisory Group's portfolio in Q3 2026, its #295 holding.
  • VisionPoint Advisory Group first reported a position in Repligen in Q4 2025 and has held it in 3 quarters since.
  • 76 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on VisionPoint Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.